Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Posts
- Category: important (continued)
- New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington's Disease
- New discovery is a step towards developing Huntington’s disease treatments before symptoms appear
- New Evidence: How Amino Acid Cysteine Combats Huntington’s Disease
- New insight into Huntington’s disease may open door to drug development
- New study offers hope for Huntington’s Disease patients
- New study reveals a potential HD biomarker
- News flash: Isis and Roche hope to start Huntington’s gene-silencing trial in first half of 2015
- NOTIZIARIO AICH - ROMA APRILE 2014
- NOTIZIARIO AICH – ROMA AGOSTO 2014
- Novel RNAi Therapy Silences Mutated Huntington's Disease Gene and Reduces Symptoms
- Novità per la cura della malattia di Huntington
- NUB1: enhancing clearance to decrease mutant huntingtin
- ORNL, UTGSM study compares structures of Huntington’s disease protein
- PBT2 recommended for orphan designation in Europe
- Pitt Study Shows for First Time How Huntington’s Disease Protein Could Cause Death of Neurons
- Possible new treatment for neurodegenerative diseases found
- Potential new treatments for depression uncovered by research into Huntington's
- Potential Therapeutic Target for Huntington’s Disease
- Potential Treatment for Huntington's Disease, Found Effective, Safe in Mice, Monkeys, Enters Clinical Testing
- Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
- Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington diseaseread more
- PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
- Progress at the Scientific Planning Committee
- Promising approach to slow brain degeneration in a model of Huntington's disease uncovered
- Protein aggregates in cytoplasm interfere with important transport routes
- PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington's Disease
- Raptor announces results of cysteamine trial for Huntington's disease
- Researchers find important new piece in the Huntington’s disease puzzle
- Researchers identify how a single gene can protect against causes of neurodegenerative diseases
- Researchers identify new potential drug target for Huntington's disease
- Roche announces details of its 'pivotal' huntingtin-lowering study
- Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
- Scientists hunt down origin of Huntington's disease in the brain
- Scripps Florida Scientists Uncover Major Factor in Development of Huntington’s Disease
- SIGNAL: A new investigational approach to early treatment of Huntington’s disease
- Sleep, cilia and HD
- Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
- Stanford study identifies new biomarkers for Huntington's disease
- Statement of the EHDN Executive Committee about the PRIDE-HD trial
- Structural Genomics Consortium and CHDI Foundation announce open-access collaboration to discover new drug targets for Huntington’s disease
- Structure of brain plaques in Huntington's disease described
- Study discovers novel therapeutic targets for Huntington's disease
- Study Suggests Potential Therapy for Huntington’s Disease
- SVELATA LA GENESI DEI NEURONI DELLO STRIATO
- Swapping Sick for Healthy Brain Cells Slows Huntington’s Disease
- Synthetic gene circuits pump up cell signals
- Synthetic Oil Drug May Bring Promise for Huntington’s Disease
- TAU DISCOVERS THAT PROTEIN CLUSTERS IMPLICATED IN NEURODEGENERATIVE DISEASES ACTUALLY SERVE TO PROTECT BRAIN CELLS
- Tetrabenazine in the therapy of choreic movements: the point of view of Jo Jankovic
- Teva Advances Pipeline of Movement Disorder Assets with Announcement of Positive Top-Line Data from the First Pivotal Study of Investigational Treatment for Patients with Tardive Dyskinesia
Plugin by dagondesign.com
